NCT02107482View on ClinicalTrials.gov

Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Psoriasis
Interventions
DEVICE

Levia Narrow Band UVB

The device's spectral output is is Narrow Band UVB (NB-UVB) (NB-Levia): 308-312 nm

DEVICE

Levia sham/visible-light source

the light spectrum is in the range of 400-700nm, the light is produced using the same Levia® device. Levia® enable the user to switch off the UVB light and only produce visible light spectrum.

Trial Locations (1)

02111

Dermatology Research, Tufts Medical Center, Boston

All Listed Sponsors
lead

Tufts Medical Center

OTHER

NCT02107482 - Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis | Biotech Hunter | Biotech Hunter